Determination of critical manufacturing and formulation variables for a hydrophilic matrix tablet formulation using an in vitro discriminatory dissolution method.
Stark
P
P
IVIVR Co-operative Working Group, Elan Corporation plc, Athlone, Co. Westmeath, Ireland.
Kinahan
A
A
Cunningham
S
S
Butler
J
J
O'Hara
T
T
Dunne
A
A
Connolly
J
J
Devane
J
J
D055598:Chemical Phenomena; D002626:Chemistry, Pharmaceutical; D002627:Chemistry, Physical; D003692:Delayed-Action Preparations / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D004339:Drug Compounding; D006801:Humans; D065347:Hypromellose Derivatives; D066298:In Vitro Techniques; D008747:Methylcellulose / Q000031:analogs & derivatives / Q000737:chemistry; D010316:Particle Size; D013607:Tablets
D003692:Delayed-Action Preparations; D013607:Tablets; D065347:Hypromellose Derivatives; D008747:Methylcellulose